CD63 and breast cancer: According to the study conducted by Gao et al., CD63+ cancer-associated fibroblasts (CAFs) secreted miR-22-enriched exosomes that could mitigate ERα expression and activate the PI3K/AKT pathway via PTEN downregulation to promote TAM resistance in BC cells (Gao et al., 2020).